Command Palette

Search for a command to run...

ANUHPHR

80.5-2.10%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Anuh Pharma Ltd. is currently lagging behind its peers in key financial metrics. While it shows no significant debt, its lack of growth and profitability metrics indicates a need for improvement. In contrast, companies like Sun Pharmaceuticals and Dr. Reddy's Laboratories exhibit strong growth and profitability, making them sector leaders. Anuh Pharma's current valuation appears attractive, but without evident growth, it may not be a compelling investment at this time.

Key Points
  • Anuh Pharma has no growth metrics reported, indicating stagnation.
  • Sun Pharmaceuticals and Dr. Reddy's Laboratories are outperformers with significant growth and profitability.
  • Anuh Pharma maintains a low debt level, but it lacks competitive profitability and growth indicators.
Top Performers
Sun Pharmaceutical Industries Ltd.

Strong revenue growth (YoY: 8.42%) and high profitability metrics with a ROE of 16.13%.

Dr. Reddy's Laboratories Ltd.

Solid growth trajectory with 16.54% revenue growth YoY and a strong ROE of 21.76%.

Cipla Ltd.

Promising revenue growth of 13.28% YoY and a decent ROE of 16.63%.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.